Article 103. Testing of drugs, drug materials and primary packages of drugs
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
QUY CHUẨN, TIÊU CHUẨN CHẤT LƯỢNG VÀ VIỆC KIỂM NGHIỆM THUỐC, NGUYÊN LIỆU LÀM THUỐC, BAO BÌ TIẾP XÚC TRỰC TIẾP VỚI THUỐC
1. Testing of drugs, drug materials and primary packages of drugs includes taking samples, considering their technical standards, and conducting relevant and necessary tests in order to identify whether they satisfy quality standards then decide whether to accept or discard them.
2. Before being used for drug manufacture, drug materials and primary packages of drugs shall be tested to ensure that they satisfy quality standards.
3. Before being delivered, drugs, drug materials and primary packages of drugs shall be tested by manufacturing establishments to ensure that they satisfy quality standards.
4. In addition to being tested under Clause 3 of this Article, the following drugs shall, before being put in circulation, be tested by a drug testing establishment designated by a competent state agency:
a/ Vaccines;
b/ Biological products which are antisera;
c/ Other drugs as prescribed by the Ministry of Health, based on the results of assessment of drug quality risks and the situation of manufactured and imported drugs.
5. The Minister of Health shall detail this Article.
Article 103, Law 105/2016/QH13